Related Experiment Video
Updated: May 24, 2026
Inducible and Reversible Dominant-negative (DN) Protein Inhibition
Published on: January 7, 2019
Repression of germline RNAi pathways in somatic cells by retinoblastoma pathway chromatin complexes
Xiaoyun Wu1, Zhen Shi, Mingxue Cui
1Department of Molecular Biology, Massachusetts General Hospital, Boston, Massachusetts, United States of America.
Abstract:
The retinoblastoma (Rb) tumor suppressor acts with a number of chromatin cofactors in a wide range of species to suppress cell proliferation. The Caenorhabditis elegans retinoblastoma gene and many of these cofactors, called synMuv B genes, were identified in genetic screens for cell lineage defects caused by growth factor misexpression. Mutations in many synMuv B genes, including lin-35/Rb, also cause somatic misexpression of the germline RNA processing P granules and enhanced RNAi. We show here that multiple small RNA components, including a set of germline-specific Argonaute genes, are misexpressed in the soma of many synMuv B mutant animals, revealing one node for enhanced RNAi. Distinct classes of synMuv B mutants differ in the subcellular architecture of their misexpressed P granules, their profile of misexpressed small RNA and P granule genes, as well as their enhancement of RNAi and the related silencing of transgenes. These differences define three classes of synMuv B genes, representing three chromatin complexes: a LIN-35/Rb-containing DRM core complex, a SUMO-recruited Mec complex, and a synMuv B heterochromatin complex, suggesting that intersecting chromatin pathways regulate the repression of small RNA and P granule genes in the soma and the potency of RNAi. Consistent with this, the DRM complex and the synMuv B heterochromatin complex were genetically additive and displayed distinct antagonistic interactions with the MES-4 histone methyltransferase and the MRG-1 chromodomain protein, two germline chromatin regulators required for the synMuv phenotype and the somatic misexpression of P granule components. Thus intersecting synMuv B chromatin pathways conspire with synMuv B suppressor chromatin factors to regulate the expression of small RNA pathway genes, which enables heightened RNAi response. Regulation of small RNA pathway genes by human retinoblastoma may also underlie its role as a tumor suppressor gene.
Insights
The retinoblastoma (Rb) tumor suppressor and its cofactors regulate small RNA pathways. This research identifies three distinct synMuv B chromatin complexes that control gene expression and RNA interference, impacting tumor suppression.
Area of Science:
- Molecular Biology
- Genetics
- Epigenetics
Background:
- The retinoblastoma (Rb) tumor suppressor is crucial for suppressing cell proliferation across species.
- SynMuv B genes, including lin-35/Rb, were identified through genetic screens for cell lineage defects.
- Mutations in synMuv B genes lead to misexpression of germline P granules and enhanced RNA interference (RNAi) in the soma.
Purpose of the Study:
- To investigate the molecular mechanisms underlying enhanced RNAi in synMuv B mutants.
- To identify the specific chromatin complexes involved in regulating small RNA and P granule gene expression.
- To elucidate the role of intersecting chromatin pathways in controlling RNAi potency and tumor suppression.
Main Methods:
- Genetic screens in Caenorhabditis elegans to identify synMuv B genes.
- Analysis of small RNA components and P granule gene misexpression in synMuv B mutant animals.
- Genetic interaction studies involving chromatin regulators like MES-4 and MRG-1.
Main Results:
- Multiple small RNA components and germline-specific Argonaute genes are misexpressed in the soma of synMuv B mutants.
- Distinct classes of synMuv B mutants exhibit differences in P granule architecture, small RNA profiles, and RNAi enhancement.
- Three classes of synMuv B genes define distinct chromatin complexes: DRM, Mec, and synMuv B heterochromatin complex.
- These complexes intersect to regulate small RNA and P granule gene repression and RNAi potency.
- Genetic interactions reveal additive effects between DRM and heterochromatin complexes and antagonistic interactions with MES-4 and MRG-1.
Conclusions:
- Intersecting synMuv B chromatin pathways, along with suppressor chromatin factors, regulate small RNA pathway genes, enabling heightened RNAi.
- The identified chromatin complexes provide a framework for understanding the regulation of small RNA pathways.
- Regulation of small RNA pathway genes by human retinoblastoma may contribute to its function as a tumor suppressor.
Related Concept Videos
01:20The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
01:20The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
02:15Experimental RNAi
03:17Inheritance of Chromatin Structures
02:57piRNA - Piwi-interacting RNAs
01:23Negative Regulator Molecules